Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Jennifer Doudna
Jennifer Doudna
Scribe's CRISPR tech Prevails in new $1.5B biobucks deal with Lilly unit
Fierce Biotech
Tue, 05/16/23 - 12:01 pm
Scribe Therapeutics
Eli Lilly
CRISPR
Prevail Therapeutics
gene therapy
biobucks
Jennifer Doudna
Sanofi and Jennifer Doudna-Founded Scribe ink $1B CRISPR cell therapy deal
Pharma Live
Tue, 09/27/22 - 10:23 am
Sanofi
Scribe Therapeutics
CRISPR
Jennifer Doudna
gene editing
CRISPR debuted 10 years ago, in a paper hardly anyone noticed. Jennifer Doudna reflects on the DNA scissors’ first decade
Stat
Tue, 06/28/22 - 10:31 am
CRISPR
gene editing
Jennifer Doudna
Drugs based on next-generation gene editing are moving toward the clinic faster than CRISPR 1.0
Stat
Thu, 02/10/22 - 10:25 am
CRISPR
gene editing
Jennifer Doudna
Bayer jumps on board Mammoth's ultra-small CRISPR tech with sights set first on liver disease
Endpoints
Mon, 01/10/22 - 11:28 am
Bayer
CRISPR
Jennifer Doudna
Mammoth Biosciences
Jennifer Doudna Reacts to Intellia CRISPR Breakthrough, Outlines Challenges
BioSpace
Fri, 07/2/21 - 11:01 am
Jennifer Doudna
CRISPR
Intellia Therapeutics
The incubator that hatched a Jennifer Doudna CRISPR startup blueprints new 'destination for life science entrepreneurship'
EP Vantage
Tue, 05/11/21 - 11:02 am
Caribou Biosciences
Zymergen
incubators
QB3
Jennifer Doudna
Jennifer Doudna’s Second Act: COVID-19 and Beyond
BioSpace
Wed, 03/10/21 - 11:16 am
Jennifer Doudna
CRISPR
COVID-19
pandemic
Doudna-founded biotech Caribou raises fresh funds to fuel gene editing pipeline
BioPharma Dive
Wed, 03/3/21 - 11:00 am
Caribou Biosciences
Jennifer Doudna
CRISPR
gene editing
Nobel Prize in chemistry goes to CRISPR pioneers Doudna, Charpentier
Fierce Biotech
Wed, 10/7/20 - 11:06 am
Nobel Prize
chemistry
Jennifer Doudna
Emmanuelle Charpentier
CRISPR
Jennifer Doudna’s New Gene Editing Company Launches With A $20 Million Round To Develop Genetic Medicines
Forbes
Tue, 10/6/20 - 11:16 pm
Jennifer Doudna
gene editing
Scribe Therapeutics
ALS
A Jennifer Doudna-led team finds a new CRISPR enzyme in the giant viruses of a California mud bog
Endpoints
Fri, 07/17/20 - 11:11 am
Jennifer Doudna
CRISPR
viruses
Mammoth Biosciences, GSK partner on CRISPR-based Covid-19 diagnostic
MedCity News
Wed, 05/20/20 - 12:20 pm
Mammoth Biosciences
GSK
CRISPR
diagnostics
COVID-19
Jennifer Doudna
CRISPR pioneer Doudna opens lab to run Covid-19 tests
Stat
Mon, 03/30/20 - 10:35 am
Jennifer Doudna
CRISPR
laboratories
diagnostics
COVID-19